Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9001910 | Biochemical Pharmacology | 2005 | 12 Pages |
Abstract
Agonists of the peroxisome proliferator activated receptor gamma (PPARγ) are currently used for treatment of type 2 diabetes due to their insulin sensitizing and glucose metabolism stabilizing effects. More recently some of these same agonists were shown to exert anti-inflammatory and anti-proliferative effects as well. Although PPARγ agonists can operate via receptor-mediated events occurring at the genomic level, thereby causing long lasting changes in gene expression patterns, recent studies demonstrate non-genomic as well as genomic actions, and receptor-dependent as well as receptor-independent effects of the thiazolidinedione (TZD) class of PPARγ agonists. In this review we will summarize data describing some of these novel, receptor independent actions of TZDs, review evidence that TZDs directly influence mitochondrial function, and attempt to reconcile how changes in mitochondrial function could contribute to other receptor-independent actions of these drugs.
Keywords
CPT1ERKHSRNOSPPARγHspIκBΔΨmCBPIKKGadd45EGR-1GLUTNOS2VCAM-1CREBAP1TZDPDHPGC1αNAG-1inhibitor of nuclear factor kappa BPGJ2Prostaglandin J2c-Jun NH2-terminal protein kinaseTNFTROGcyclic AMP-responsive element binding proteingrowth arrest and DNA damage-inducible genePPARγ coactivator 1αAMPKLPSJnkFFAAICARCOXAUCDMSOIκB kinasemalonyl-CoA decarboxylaseMAPKNFκBpIOSmall interfering RNAROSsiRNAadenosine 5′-monophosphate-activated protein kinasecyclooxygenasePPREFatty acidFree fatty acidinsulininterferonIFNinterleukinTroglitazoneThiazolidinedioneGlucose transporterCNSDimethyl sulfoxideROSIrosiglitazoneCytokinescentral nervous systemextracellular signal regulated kinasetumor necrosis factornuclear factor kappa BHuman leukemialipopolysaccharideMetabolismarea under the curvevascular cell adhesion molecule-1MitoNEETMitochondriaNitric oxidenitric oxide synthaseStress responseearly growth response-1Heat shock responseMitochondrial membrane potentialCREB-binding proteinHeat shock proteinactivator protein 1Protein kinaseprostaglandinpyruvate dehydrogenasemitogen-activated protein kinasesPioglitazoneGlucoseReactive oxygen speciesPeroxisome proliferator activated receptor gamma
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
D.L. Feinstein, A. Spagnolo, C. Akar, G. Weinberg, P. Murphy, V. Gavrilyuk, C. Dello Russo,